Plasma multi-miRNA models classify Alzheimer's, Parkinson's, and Lewy body dementia.
Overview
- Department of Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, OR, United States
- Biostatistics & Design Program, Oregon Health & Science University, Portland, OR, United States
- Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States
- Department of Neurology, University of Washington, Seattle, WA, United States
- Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, United States
- Department of Neurology, Oregon Health & Science University, Portland, OR, United States
- Parkinson Center and Movement Disorders Program, Oregon Health & Science University, Portland, OR, United States
- Portland VAMC Parkinson's Disease Research, Education, and Clinical Center, Portland, OR, United States
Abstract
Introduction: Differentiating Alzheimer’s disease (AD) from both Parkinson’s disease (PD) and Lewy body dementia (DLB) is difficult due to their clinical similarities. Plasma biomarkers offer an alternative to neuroimaging and cerebrospinal fluid analysis; however, there are limitations with respect to differential diagnosis of AD, PD, and DLB with current clinical assays.
Methods: Here we used machine learning to assess plasma miRNAs for their specificity in diagnosing AD vs. PD, and DLB. Our multi-center study assayed 57 AD-associated miRNAs in human plasma from 82 cognitively normal controls (NC), 87 AD, 100 PD, and 20 DLB. Predictive models generated by three independent machine learning methods were evaluated by cross-validated ROC curves [cvAUC (bootstrap bias-corrected 95% CI)]. We also used linear discriminant analysis with all 57 miRNAs to identify a model that best separates AD from PD + DLB participants and DLB from AD+PD participants. Further, we used Target prediction and Ingenuity Pathway Analysis to identify highly relevant mRNA targets of the miRNAs.
Results: Individual assessment of the 57 miRNAs identified a subset of 10 miRNAs that were more AD-specific, and 23 miRNAs that were more PD and/
Discussion: These data demonstrate that predictive modeling using plasma miRNA expression data may improve the differential diagnosis of AD from PD from DLB.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE338073, at NCBI GEO; found in “Data availability statement”
Data availability statement
All data used for statistical comparisons in this study, the amplification flag summary by miRNA and experimental group used to select miRNAs for differential expression or differential detection, and the datasets generated for this study are publicly available in the Gene Expression Omnibus Accession site: https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 9 authors, 8 keywords, 2 funders, 73 references.
Cite
This paper
Sandau, U. S., Wiedrick, J. T., McFarland, T. J., Yearout, D., Zabetian, C. P., Hu, S.-C., Tsuang, D. W., Quinn, J. F., & Saugstad, J. A. (2026). Plasma multi-miRNA models classify Alzheimer's, Parkinson's, and Lewy body dementia. Frontiers in aging neuroscience, 18, 1788991. https://
BibTeX
@article{sandau2026plasm
author = {Sandau, Ursula S. and Wiedrick, Jack T. and McFarland, Trevor J. and Yearout, Dora and Zabetian, Cyrus P. and Hu, Shu-Ching and Tsuang, Debby W. and Quinn, Joseph F. and Saugstad, Julie A.},
title = {{Plasma multi-miRNA models classify Alzheimer's, Parkinson's, and Lewy body dementia}},
journal = {Frontiers in aging neuroscience},
year = {2026},
month = aug,
volume = {18},
pages = {1788991},
publisher = {Frontiers Media SA},
issn = {1663-4365},
doi = {10.3389/
url = {https://
pmid = {42643339},
pmcid = {PMC13503333}
}
RIS
TY - JOUR
AU - Sandau, Ursula S.
AU - Wiedrick, Jack T.
AU - McFarland, Trevor J.
AU - Yearout, Dora
AU - Zabetian, Cyrus P.
AU - Hu, Shu-Ching
AU - Tsuang, Debby W.
AU - Quinn, Joseph F.
AU - Saugstad, Julie A.
TI - Plasma multi-miRNA models classify Alzheimer's, Parkinson's, and Lewy body dementia
T2 - Frontiers in aging neuroscience
J2 - Front Aging Neurosci
PY - 2026
DA - 2026/
VL - 18
SP - 1788991
SN - 1663-4365
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Plasma multi-miRNA models classify Alzheimer's, Parkinson's, and Lewy body dementia",
"container-title": "Frontiers in aging neuroscience",
"author": [
{
"family": "Sandau",
"given": "Ursula S."
},
{
"family": "Wiedrick",
"given": "Jack T."
},
{
"family": "McFarland",
"given": "Trevor J."
},
{
"family": "Yearout",
"given": "Dora"
},
{
"family": "Zabetian",
"given": "Cyrus P."
},
{
"family": "Hu",
"given": "Shu-Ching"
},
{
"family": "Tsuang",
"given": "Debby W."
},
{
"family": "Quinn",
"given": "Joseph F."
},
{
"family": "Saugstad",
"given": "Julie A."
}
],
"container-title-short":
"volume": "18",
"page": "1788991",
"DOI": "10.3389/
"PMID": "42643339",
"PMCID": "PMC13503333",
"ISSN": "1663-4365",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
11
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1038/s41598-025-33589-0
- Comparison of multi-miRNA models from donor-matched plasma and cerebrospinal fluid as candidate biomarkers for Alzheimer's disease prediction.Journal: Scientific reportsIn common: Alzheimer's / dementia, 18 references
- [2] doi:10.3389/fgene.2023.1231486
- A new perspective on Alzheimer's disease: microRNAs and circular RNAs.Journal: Frontiers in geneticsIn common: Alzheimer's / dementia, cellular / molecular, 9 references
- [3] doi:10.1038/s41380-026-03487-6
- Rethinking Alzheimer's: novel miRNAs illuminate a disease beyond the brain.Journal: Molecular psychiatryIn common: Alzheimer's / dementia, cellular / molecular, 8 references
- [4] doi:10.1038/s42003-026-09530-0
- Differentially expressed miRNAs in the temporal cortex of Alzheimer's disease patients and their association to tau pathology.Journal: Communications biologyIn common: Alzheimer's / dementia, cellular / molecular, 7 references
- [5] doi:10.1038/s44328-026-00086-x [code]
- Microfluidic nanomagnetically isolated neuron- and astrocyte-derived extracellular vesicles to differentiate Lewy body and Alzheimer's disease.Journal: Npj biosensingIn common: Alzheimer's / dementia, cellular / molecular, 5 references
- [6] doi:10.3389/fgene.2022.880997 [code]
- Identifying Key MicroRNA Signatures for Neurodegenerative Diseases With Machine Learning Methods.Journal: Frontiers in geneticsIn common: Alzheimer's / dementia, cellular / molecular, 4 references
- [7] doi:10.3390/ijms26178218
- The Role of miRNAs in the Differential Diagnosis of Alzheimer's Disease and Major Depression: A Bioinformatics-Based Approach.Journal: International journal of molecular sciencesIn common: Alzheimer's / dementia, 4 references
- [8] doi:10.1186/s13293-024-00588-1
- The role of microRNAs in understanding sex-based differences in Alzheimer's disease.Journal: Biology of sex differencesIn common: Alzheimer's / dementia, cellular / molecular, 3 references
- [9] doi:10.7150/thno.81826
- Decreased miR-451a in cerebrospinal fluid, a marker for both cognitive impairment and depressive symptoms in Alzheimer's disease.Journal: TheranosticsIn common: Alzheimer's / dementia, cellular / molecular, 3 references
- [10] doi:10.15252/emmm.202013659 [code]
- A microRNA signature that correlates with cognition and is a target against cognitive decline.Journal: EMBO molecular medicineIn common: Alzheimer's / dementia, cellular / molecular, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
